Printed From BioPortfolio.com
Commense, Inc. Company Profile
14:46 EST 23rd January 2019 | BioPortfolio
Commense, Inc., an affiliate of PureTech Health (LSE: PRTC), is
developing interventions for pediatric and maternal health based on a
deep understanding of the microbiome and its fundamental role as the
foundation for the development of immune tolerance. Commense is working
with some of the worldâs leading microbiome scientists, physicians, and
researchers to develop therapeutics comprised of rationally defined
consortia of microbes to address critical unmet needs in pediatric
populations. These defined microbial therapies are based on a deep
understanding of human-microbe interactions, the effects of microbes on
the immune system, and the impact of these interactions on infant and
maternal health.
News Articles
None
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Commense, Inc., an affiliate of PureTech Health (LSE: PRTC), is developing interventions for pediatric and maternal health based on a deep understanding of the microbiome and its ...
More Information about "Commense, Inc." on BioPortfolio
We have published hundreds of Commense, Inc. news stories on BioPortfolio along with dozens of Commense, Inc. Clinical Trials and PubMed Articles about Commense, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Commense, Inc. Companies in our database. You can also find out about relevant Commense, Inc. Drugs and Medications on this site too.
